JADE101

DRUG3 trials

Sponsors

Jade Biosciences, Inc.

Conditions

Healthy VolunteersHealthy Volunteers (HV)IgA Nephropathy

Phase 1

A Phase 1 Study of JADE101 in Healthy Participants

Active, not recruitingNCT07059312

Jade Biosciences, Inc.Healthy Volunteers

Start: 2025-08-17End: 2026-10-31Updated: 2025-12-18

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

RecruitingNCT07525947

Jade Biosciences, Inc.Healthy Volunteers (HV)

Start: 2026-05-01End: 2027-05-01Target: 40Updated: 2026-06-04

Phase 2

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

RecruitingNCT07541287

Jade Biosciences, Inc.IgA Nephropathy

Start: 2026-05-19End: 2029-04-01Target: 30Updated: 2026-08-20